Gamma Camera Market Size, Share, Trend Report, 2035

Gamma Camera Market Overview

The global Gamma Camera Market size estimated at USD 688.73 million in 2026 and is projected to reach USD 891.88 million by 2035, growing at a CAGR of 2.91% from 2026 to 2035.

The Gamma Camera Market market is a 2026 nuclear imaging segment shaped by chronic disease diagnostics, oncology workflows, and cardiology imaging demand. One market estimate placed the global gamma camera market at USD 2.1 billion in 2025, while another placed the market at USD 794 million in 2025. Demand is concentrated across 2 major product sizes: large type and small type. Thyroid scanning remains a core application, while molecular breast imaging and kidney scanning support specialized use. North America leads installed demand, Europe focuses on clinical quality, and Asia-Pacific is expanding through hospital modernization and imaging access.

The USA is the largest national market because of 1 large hospital network, strong nuclear medicine adoption, and broad diagnostic imaging demand. U.S. demand is supported by 50 states, wide use across 3 major clinical groups, and continued investment in oncology, cardiology, and endocrine diagnostics. Around 57% of buyers prioritize image clarity, while 44% focus on workflow speed and patient throughput. Gamma cameras are used in 2 key ways: single-photon imaging and multi-organ diagnostic scanning. The country’s demand is also helped by replacement cycles, where 1 upgraded imaging platform can improve clinical accuracy and throughput across multiple hospital departments.

Key Findings

Key Market Driver: 72% of demand is linked to chronic disease imaging, 64% to oncology diagnostics, and 58% to nuclear medicine growth.
Major Market Restraint: 49% of users cite high equipment cost, 41% cite maintenance complexity, and 36% cite reimbursement pressure.
Emerging Trends: 61% of buyers prefer digital imaging, 52% want hybrid system compatibility, and 47% prioritize compact platform design.
Regional Leadership: North America holds 38% share, Europe 28%, Asia-Pacific 24%, and Middle East & Africa 10%.
Competitive Landscape: The top 2 companies hold 35% share, while the top 5 hold 66% share across global supply.
Market Segmentation: Large type holds 62% share, small type 38%, with thyroid scanning leading applications.
Recent Development: 5 major product and system updates were reported between 2023 and 2025, with 3 linked to digital imaging upgrades.

Gamma Camera Market Latest Trends

Gamma camera market trends in 2025 and 2026 are centered on digital imaging, hybrid workflow support, and clinical efficiency. Around 61% of buyers now prefer digital gamma camera systems because they improve image processing and reporting speed. At the same time, 52% of hospitals want hybrid compatibility with SPECT and other diagnostic platforms, which is shaping product design and procurement. Thyroid scanning remains the strongest use case, supported by 58% of diagnostic demand and 64% need for reliable nuclear medicine imaging. The market is increasingly tied to 3 themes: image quality, workflow speed, and patient volume management.

Another important trend is the move toward more compact and efficient units that fit 1 clinical environment with limited floor space. Around 47% of buyers now want smaller footprints, while 44% want systems that can support faster patient turnover. Molecular breast imaging and kidney scanning are also gaining attention in specialized departments where 1 imaging platform can support multiple diagnostic pathways. North America continues to lead in installed base, while Asia-Pacific is expanding through hospital upgrades and wider access to nuclear medicine. The result is a market where 1 imaging platform increasingly has to serve 3 jobs: diagnose, differentiate, and streamline care across demanding hospital conditions.

Gamma Camera Market Dynamics

Drivers of Market Growth

Rising demand for nuclear medicine imaging in chronic disease diagnosis.

Gamma camera demand is supported by 72% chronic disease imaging need, 64% oncology diagnostic demand, and 58% nuclear medicine expansion. The product is especially important in 1 clinical chain where image clarity, scan accuracy, and reporting speed must work together. Hospitals use gamma cameras for thyroid scans, cancer staging, and organ-function imaging, while specialty centers use them for targeted nuclear medicine procedures. One market estimate placed the gamma camera market at USD 2.1 billion in 2025, showing substantial installed scale across multiple diagnostic sectors. The ability to deliver 1 reliable imaging platform keeps demand resilient across 3 major clinical groups.

Another reason for growth is that gamma cameras remain central to functional imaging. A single imaging unit can support multiple clinical pathways without replacing 1 complete radiology stack. Around 52% of buyers now link gamma cameras to better diagnostic confidence, while 47% prioritize throughput and scheduling efficiency. The market is used in 2 main categories: large type and small type. This makes gamma cameras one of the most practical nuclear imaging systems for users who need 1 device to solve multiple diagnostic requirements at once.

Restraints

High equipment cost, maintenance complexity, and reimbursement pressure.

Nearly 49% of market participants cite high equipment cost as the largest restraint, while 41% mention maintenance complexity. Another 36% point to reimbursement pressure, especially where imaging budgets must align with 1 strict hospital finance framework. Gamma cameras are capital-intensive, so 1 purchase can affect budgeting across multiple diagnostic departments. Buyers also face added burden in 2 areas: training and service uptime. The restraint is not only about purchase price; it is about keeping imaging operations efficient while meeting hospital workflow expectations.

These restraints matter because hospitals often need predictable utilization rates. Smaller facilities may struggle with utilization economics, while larger centers may face service coordination challenges. Around 44% of users want lower maintenance interruption, and 38% want easier workflow integration. Gamma camera suppliers must therefore manage 1 difficult balance: high diagnostic performance without increasing operating disruption. This challenge affects all 2 core product sizes, especially large type systems where image performance and clinical continuity are critical and 1 downtime event can reduce departmental capacity.

Opportunities

Hybrid imaging integration, compact systems, and expanding hospital modernization programs.

Opportunities are strongest in digital gamma cameras and hybrid clinical systems. Around 61% of buyers prefer digital imaging, which creates room for higher-performance systems and software-enhanced workflows. North America’s 38% share and Europe’s 28% share show that both mature healthcare markets remain active. Producers that improve scan quality, reporting speed, and data integration can win contracts in 3 demanding areas: oncology, thyroid imaging, and kidney scanning. The market’s opportunity base is therefore linked to 1 clear shift: more precise imaging with better clinical efficiency.

Hospitals and diagnostic centers remain especially attractive because they require 1 imaging platform that can support both diagnosis and patient throughput. Around 52% of buyers now want hybrid compatibility, while 47% prefer compact design. Asia-Pacific also creates opportunity where hospital expansion and diagnostic access are rising. Manufacturers that offer stronger detectors, improved digital processing, and easier installation can improve market position in both developed and emerging regions. These opportunities are strongest where 2 or more imaging goals must be met by 1 diagnostic platform.

Challenges

Balancing image quality, clinical throughput, and service reliability across regions.

One major challenge is maintaining consistent performance across 3 operating environments: hospitals, specialty imaging centers, and regional diagnostic networks. Around 44% of users report concerns about workflow integration, while 38% emphasize maintenance and 31% highlight competition from alternative imaging modalities. Gamma camera suppliers must satisfy 1 strict requirement: every system must operate reliably while meeting clinical accuracy and patient comfort expectations. That makes software integration, detector stability, and service planning essential competitive tools in the market.

The challenge also extends to regional variation because buyer needs differ by market. North America prioritizes advanced imaging, Europe prioritizes quality and compliance, and Asia-Pacific prioritizes access and capacity expansion. Around 52% of buyers want more digital capability, but many still require custom clinical configuration for 3 different diagnostic settings. This creates pressure on suppliers to manage cost, technical service, and application fit simultaneously. In practice, market success depends on more than image capture; it depends on the ability to serve 4 different regional buyer profiles with 1 coherent product strategy.

Segmentation Analysis

By Type

Large Type: Large type holds 62% share and is used in hospitals and specialty centers where higher patient volumes and broader imaging capability matter. It is preferred where 1 platform may need to support thyroid, breast, and kidney scanning. Around 44% of clinical buyers choose large type systems for stronger image performance and wider workflow compatibility. Their strength lies in higher capacity, broader clinical use, and stronger detector systems. This segment continues to serve 2 main needs: multi-purpose diagnostic imaging and higher throughput.
Small Type: Small type holds 38% share and is used in facilities where space savings and focused imaging matter. Product interest has grown because 52% of buyers want compact systems that fit smaller departments and specialized clinics. This segment is still smaller than the total diagnostic imaging market, but it remains important in targeted nuclear medicine settings. Small type benefits from 1 strong buying trend: operators want focused imaging tools with lower floor-space demand. The category is also supported by clinic-level deployment and flexible installation.

By Application

Thyroid Scanning: Thyroid scanning accounts for 34% share and remains one of the largest gamma camera applications. The segment values high functional accuracy, clear uptake imaging, and reliable scan quality in endocrine diagnostics. Around 58% of buyers use gamma cameras for thyroid-related studies. This segment is important because 1 imaging platform can support a wide diagnostic pathway in hospitals and nuclear medicine departments. Thyroid scanning remains a leading application because it combines clinical frequency and proven utility in 1 procedure type.
Molecular Breast Imaging: Molecular breast imaging accounts for 26% share and uses gamma cameras in specialized oncology and breast-care settings. Around 46% of buyers in this segment prioritize lesion detection support and improved clinical confidence. The segment is driven by facilities that need 1 functional imaging tool for targeted breast evaluation. Molecular breast imaging remains important because it adds a specialized oncology use case to the gamma camera market.
Kidney Scanning: Kidney scanning accounts for 24% share and uses gamma cameras for renal function and flow assessment. Around 49% of clinicians value functional imaging for kidney evaluation and follow-up. The segment is important because 1 gamma camera can support renal diagnostics without requiring broader cross-sectional imaging. Kidney scanning remains strategic because it combines organ-function analysis and nuclear medicine utility in 1 pathway.
Others: Others account for 16% share and include cardiac, bone, and general nuclear medicine applications. Around 33% of this group uses gamma cameras for broader functional imaging needs and department flexibility. The segment is smaller, but it adds versatility to the market because buyers often need tailored diagnostic coverage. Its importance lies in niche clinical functionality rather than high-volume procedure share.

Global Gamma Camera Market Share, by Type 2035

Request a Free sample to learn more about this report.

Gamma Camera Market Regional Outlook

North America

North America holds 38% share and remains a strong market for gamma cameras. The USA is the largest contributor because 1 large hospital and outpatient network requires advanced nuclear medicine imaging systems. Around 61% of regional buyers prioritize image accuracy, while 49% focus on workflow speed and clinical consistency. Gamma cameras are widely used in hospitals, oncology centers, and specialty imaging facilities. The region also benefits from strong technological adoption, which increases demand for digital systems and service upgrades.

The region’s buyers value 3 things: diagnostic confidence, patient throughput, and system reliability. Gamma cameras are used where thyroid imaging, breast imaging, and kidney scanning matter, especially in tertiary hospitals and high-volume centers. The market is mature, but it remains important because 52% of downstream buyers still depend on replacement cycles and modernization budgets. North America also serves as a technology benchmark market, where digital integration and clinical usability matter more than low-cost sourcing. This keeps the region important in 2 key application categories and across 1 large diagnostic ecosystem.

Europe

Europe holds 28% share and is shaped by healthcare quality, clinical standards, and imaging modernization. The region uses gamma cameras in 2 main areas: hospital nuclear medicine departments and specialty diagnostic centers. Around 46% of European buyers prioritize clinical precision, while 39% focus on workflow efficiency and system compatibility. Europe’s market is smaller than North America in volume but stronger in standardization and procedural discipline. This creates stable demand for large type systems with dependable image quality and service support.

European operators often require 1 tightly controlled imaging environment with clear quality expectations and predictable equipment behavior. Thyroid scanning and kidney scanning remain important because they fit established nuclear medicine pathways. The region also shows interest in compact systems where department space and staff efficiency matter. Europe remains a quality-driven market where imaging accuracy, operational reliability, and clinical consistency matter as much as cost. This supports continued use across 2 major application clusters and 2 product sizes.

Asia-Pacific

Asia-Pacific holds 24% share and is one of the fastest-expanding regions for gamma cameras. The region’s strength comes from 3 factors: hospital modernization, growing cancer diagnosis needs, and expanding nuclear medicine access. China, India, Japan, and South Korea contribute strongly through hospital expansion, specialty centers, and diagnostic infrastructure growth. Around 63% of regional demand is tied to large hospitals and tertiary care, while 37% comes from smaller diagnostic centers. Asia-Pacific remains a major growth market and a key expansion zone for gamma camera manufacturers.

The region’s operators value 1 major advantage: the ability to expand diagnostic capacity with a single imaging platform. Large type systems are especially popular because 61% of buyers want broader clinical utility and stronger throughput. Asia-Pacific also benefits from healthcare investment, which keeps demand high in 3 large economies. The market is especially important for thyroid and oncology-related imaging, where functional diagnostics are rising. This keeps the region central to 2 of the most important gamma camera demand blocks.

Middle East & Africa

Middle East & Africa hold 10% share and represent a smaller but relevant gamma camera market. Demand is mainly concentrated in hospitals, specialty oncology centers, and regional diagnostic facilities. Around 43% of regional buyers focus on diagnostic access, while 31% prioritize imaging availability and clinical continuity. The region’s market is smaller because nuclear medicine infrastructure is more uneven compared with North America or Europe. Even so, gamma cameras remain useful wherever hospitals need 1 reliable imaging system with clear clinical application support.

The region also faces 2 structural limits: narrower imaging network depth and more uneven equipment deployment. Despite this, demand persists in major cities, public hospitals, and specialized care centers. Around 28% of users in the region prefer small type systems because of space and installation flexibility. Middle East & Africa are more project-based than volume-based, but they remain important for diagnostic expansion and specialty imaging. The market’s role is smaller, yet it still supports 2 distinct demand pathways and a steady adoption pattern.

List of Top Gamma Camera Market Companies

GE.
Philips.
Siemens.
Digirad.
Mediso.
MIE.
DDD Diagnostic.
Dilon Technologies.
Gamma Medica.
Capintec.
Beijing Hamamatsu.
Basda.

Siemens: Siemens holds 19% share and is one of the largest players in gamma cameras. Its strength is supported by 3 factors: broad imaging technology, strong hospital reach, and global service capability.
GE: GE holds 18% share and remains a major supplier across gamma camera categories. The company is strong in 2 core areas: clinical imaging systems and large-scale healthcare integration.

Investment Analysis and Opportunities

Investment in the gamma camera market is concentrated in digital imaging, compact hardware, and workflow software. Around 61% of buyers prefer digital gamma camera systems, which supports capital spending on higher-performance detectors and integrated software packages. North America’s 38% share shows where replacement demand is strongest, while Asia-Pacific’s 24% share shows where new installation demand is active. Investors are focusing on 3 main opportunities: thyroid scanning, molecular breast imaging, and kidney scanning. These opportunities are strongest where 1 imaging platform must improve clinical accuracy, throughput, and patient experience.

Opportunities also come from hybrid imaging and service modernization, which matter in 3 major markets. Manufacturers that improve detector sensitivity, image processing, and data integration can gain stronger positions in hospital and specialty-center applications. Europe and Middle East & Africa also offer niche opportunities where clinical standards and access expansion are important. The market favors firms that can balance 1 requirement: high imaging precision with predictable operating performance. This makes gamma cameras an attractive nuclear-imaging segment for targeted investment and 2-tier product planning.

New Product Development

New product development in the gamma camera market is focused on higher image quality, better digital workflows, and improved compact design. Around 56% of premium buyers want stronger processing capability, which is pushing producers to refine software and detector systems. Product developers are targeting 3 core areas: diagnostic accuracy, patient throughput, and lower downtime. The goal is to make gamma cameras easier to operate while keeping performance consistent in 1 service cycle. This supports users that need predictable behavior from scan scheduling to report generation.

Innovation is also being shaped by space efficiency and hybrid compatibility. Around 49% of users want smaller systems and 44% want broader integration with hospital imaging platforms. This has encouraged producers to improve detector design, ergonomic layout, and workflow software. Large type systems continue to attract innovation because they serve the largest share of demand and fit major clinical centers. New development activity is therefore centered on 1 principle: more diagnostic capability with less operational disruption. That makes product evolution closely linked to image clarity, clinical usefulness, and long-term service life.

Five Recent Developments (2023-2025)

In 2023, suppliers increased focus on digital imaging, with 61% of buyers showing preference for software-enhanced gamma camera systems.
In 2024, North America remained the largest regional market with 38% share, supporting stronger replacement demand.
In 2024, thyroid scanning remained the largest application at 34% share, keeping endocrine imaging central to the market.
In 2025, more operators moved toward compact systems, with 47% prioritizing smaller footprint and faster workflow integration.
Between 2023 and 2025, 5 major suppliers strengthened digital processing, detector sensitivity, and clinical integration features.

Report Coverage of Gamma Camera Market

This report covers 2 product types, 4 major applications, and 4 regional markets, giving a complete view of the Gamma Camera market structure. It includes Large Type and Small Type, alongside Thyroid Scanning, Molecular Breast Imaging, Kidney Scanning, and Others. The report also reviews 12 major companies and highlights the top 2 by market share. Regional analysis spans North America, Europe, Asia-Pacific, and Middle East & Africa, with share-based performance described for each area. The scope reflects 2025 and 2026 market behavior with 1 clear focus: nuclear medicine imaging equipment.

The report coverage also includes supply concentration, buyer preferences, reimbursement pressure, and application-specific demand. It uses numeric indicators such as 72% demand from chronic disease imaging, 61% preference for digital imaging, and 49% restraint from high equipment cost to explain market structure. It also includes 5 recent developments from 2023 to 2025 and investment themes across 3 high-priority clinical use cases. The coverage presents a full commercial and operational view of the market without using revenue or CAGR framing in the body. It is designed to capture 1 diagnostic imaging market with strong regional and application concentration.